Surgical outcomes after breast cancer surgery: Measuring acute lymphedema

被引:44
作者
Kosir, MA
Rymal, C
Koppolu, P
Hryniuk, L
Darga, L
Du, W
Rice, V
Mood, D
Shakoor, S
Wang, WL
Bedoyan, J
Aref, A
Biernat, L
Northouse, L
机构
[1] John D Dingell VA Med Ctr, Surg Sect, Detroit, MI 48201 USA
[2] Barbara Ann Karmanos Canc Inst, Breast Program, Detroit, MI USA
[3] Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA
[4] Barbara Ann Karmanos Canc Inst, Prevent Program, Detroit, MI USA
[5] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA
[6] Barbara Ann Karmanos Canc Inst, CETAID, Detroit, MI USA
[7] Wayne State Univ, Coll Nursing, Dept Family & Community Nursing, Detroit, MI 48202 USA
[8] Barbara Ann Karmanos Canc Inst, Psychosocial & Behav Oncol Core, Detroit, MI USA
[9] St Johns Hosp, Detroit, MI USA
[10] Ann Arbor Reg Community Canc Oncol Program, Ann Arbor, MI USA
[11] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA
关键词
lymphedema; breast cancer; surgical outcomes;
D O I
10.1006/jsre.2000.6021
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Studies of lymphedema have used inconsistent measures and criteria. The purpose of this pilot study was to measure the onset and incidence of acute lymphedema in breast cancer survivors using strict criteria for limb evaluation. Materials and Methods. Eligible women were those undergoing breast cancer surgery that included axillary staging and/or radiation therapy of the breast. Arm volume, strength, and flexibility were measured preoperatively and quarterly. Lymphedema was defined as a greater than 10% increase in limb volume. Additional strength and flexibility assessments were done at these times. Results. In 30 evaluable patients, half underwent modified radical mastectomy and half lumpectomy, with half of the lumpectomy patients undergoing axillary node staging. Of the 30 patients 27% were Stage 0; the rest were Stage I (27%), IIA (13%), IIB (23%), and IIIA (7%). One subject was IIIB postoperatively. There were 2 women with a 10% or greater change in limb volume; the change was detected in one woman at 3 months (5% incidence) and in the second woman at 6 months (11% incidence). Both had undergone mastectomy and axillary dissection and one of these two women had symptoms of tingling and numbness in the affected arm that began at 3 months. Overall, 35% of the sample experienced symptoms by 3 months, which included numbness, aching, and tingling of the entire upper extremity, but without volume changes, The relationship between undergoing modified radical mastectomy and experiencing symptoms in the affected limb at 3 months was significant (P = 0.05). Conclusions. In this interim report strict methods of measurement and limb volume comparisons detected acute lymphedema at 3 months in 5% of the sample, and at 6 months in 11% of the sample. Furthermore, symptoms were detected in 35% without volume changes at 3 months postoperatively, which may warn of lymphedema occurrence within the next 3 months. This may assist clinical evaluation of symptoms in the postoperative period and support early referral to lymphedema experts. (C) 2000 Academic Press.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 36 条
[1]   ARM MORBIDITY WITHIN A TRIAL OF MASTECTOMY AND EITHER NODAL SAMPLE WITH SELECTIVE RADIOTHERAPY OR AXILLARY CLEARANCE [J].
AITKEN, RJ ;
GAZE, MN ;
RODGER, A ;
CHETTY, U ;
FORREST, APM .
BRITISH JOURNAL OF SURGERY, 1989, 76 (06) :568-571
[2]  
[Anonymous], DIS BREAST
[3]   Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[4]   Focused review: Postmastectomy lymphedema [J].
Brennan, MJ ;
DePompolo, RW ;
Garden, FH .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (03) :S74-S80
[5]  
Carter B J, 1997, Oncol Nurs Forum, V24, P875
[6]  
CARTER BJ, 1993, CANCER NURS, V16, P354
[7]  
Casley-Smith JR, 1994, MODERN TREATMENT LYM, P90
[8]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[9]   THE EDINBURGH RANDOMIZED TRIAL OF AXILLARY SAMPLING OR CLEARANCE AFTER MASTECTOMY [J].
FORREST, APM ;
EVERINGTON, D ;
MCDONALD, CC ;
STEELE, RJC ;
CHETTY, U ;
STEWART, HJ .
BRITISH JOURNAL OF SURGERY, 1995, 82 (11) :1504-1508
[10]  
Gerber LH, 1998, CANCER, V83, P2803, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2803::AID-CNCR29>3.0.CO